Abstract: Provided is a resin composition containing: (A) a first cyclic imide compound of the following formula (1): wherein A independently represents a tetravalent organic group having a cyclic structure, Q independently represents an alicyclic hydrocarbon group of the formula (2): wherein R1, R2, R3, and R4 independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, and x1 and x2 are each 0 to 4, wherein B independently represents a divalent hydrocarbon group (excluding the group represented by the formula (2)), wherein X represents a hydrogen atom or a methyl group, and wherein n is 1 to 200; (B) a second cyclic imide compound of the formula (3): wherein A, B, and X are defined as above in the formula (1), and s is 0 to 200; (C) an epoxy compound; and (D) a curing catalyst.

Abstract: A liquid ejection device includes a liquid ejection head, a standby portion, a hold portion, and an operation portion. The liquid ejection head includes a nozzle surface. The standby portion supports a wiping cartridge. The hold portion holds the wiping cartridge. The operation portion moves the hold portion relatively to the standby portion and the liquid ejection head from a position at which the hold portion holds the wiping cartridge that is not held by the hold portion and that is supported by the standby portion to a position at which the wiping cartridge held by the hold portion comes into contact with the nozzle surface.

Abstract: A memory device includes a first-tier structure including a first first-tier alternating stack and a second first-tier alternating stack, a second-tier structure overlying or underlying the first-tier structure and including a first second-tier alternating stack and a second second-tier alternating stack that are laterally spaced apart from each other by a jumper alternating stack, and memory stack structures vertically extending through a respective set of at least two alternating stacks. Each of alternating stack includes a respective vertically alternating sequence of insulating layers and electrically conductive layers.

Abstract: A memory device includes source-level material layers containing a lower source-level semiconductor layer, a source contact layer, and an upper source-level semiconductor layer, an alternating stack of insulating layers and electrically conductive layers located over the source-level material layers, a memory opening vertically extending through the alternating stack and into an upper portion of the source-level material layers, and a memory opening fill structure located in the memory opening and including a memory film and a vertical semiconductor channel. The source contact layer includes a horizontally-extending portion and a vertically-extending portion having a greater vertical extent than the horizontally-extending portion, having an inner cylindrical sidewall contacting a bottom portion of the vertical semiconductor channel, and contacting a bottommost insulating layer within the alternating stack.

Abstract: Disclosed is a method of diagnosing graft-versus-host disease, comprising measuring the level of CCL8 protein in a sample obtained from a subject as an indicator for the diagnosis or course of graft-versus-host disease. Also a diagnostic reagent for graft-versus-host disease comprising an anti-CCL8 antibody is disclosed. The method of the present invention enables diagnosis of the onset of graft-versus-host disease and monitoring of the progress, in particular, differential diagnosis between graft-versus-host disease and an infectious disease. The present invention also provides a method for treating graft-versus-host disease utilizing the anti-CCL8 antibody.

Abstract: Disclosed is a method of diagnosing graft-versus-host disease, comprising measuring the level of CCL8 protein in a sample obtained from a subject as an indicator for the diagnosis or course of graft-versus-host disease. Also a diagnostic reagent for graft-versus-host disease comprising an anti-CCL8 antibody is disclosed. The method of the present invention enables diagnosis of the onset of graft-versus-host disease and monitoring of the progress, in particular, differential diagnosis between graft-versus-host disease and an infectious disease. The present invention also provides a method for treating graft-versus-host disease utilizing the anti-CCL8 antibody.

Abstract: Disclosed is a method of diagnosing graft-versus-host disease, comprising measuring the level of CCL8 protein in a sample obtained from a subject as an indicator for the diagnosis or course of graft-versus-host disease. Also a diagnostic reagent for graft-versus-host disease comprising an anti-CCL8 antibody is disclosed. The method of the present invention enables diagnosis of the onset of graft-versus-host disease and monitoring of the progress, in particular, differential diagnosis between graft-versus-host disease and an infectious disease. The present invention also provides a method for treating graft-versus-host disease utilizing the anti-CCL8 antibody.

Abstract: Disclosed is a method of diagnosing graft-versus-host disease, comprising measuring the level of CCL8 protein in a sample obtained from a subject as an indicator for the diagnosis or course of graft-versus-host disease. Also a diagnostic reagent for graft-versus-host disease comprising an anti-CCL8 antibody is disclosed. The method of the present invention enables diagnosis of the onset of graft-versus-host disease and monitoring of the progress, in particular, differential diagnosis between graft-versus-host disease and an infectious disease. The present invention also provides a method for treating graft-versus-host disease utilizing the anti-CCL8 antibody.

Abstract: Disclosed is a method of diagnosing graft-versus-host disease, comprising measuring the level of CCL8 protein in a sample obtained from a subject as an indicator for the diagnosis or course of graft-versus-host disease. Also a diagnostic reagent for graft-versus-host disease comprising an anti-CCL8 antibody is disclosed. The method of the present invention enables diagnosis of the onset of graft-versus-host disease and monitoring of the progress, in particular, differential diagnosis between graft-versus-host disease and an infectious disease. The present invention also provides a method for treating graft-versus-host disease utilizing the anti-CCL8 antibody.

Abstract: A method for producing suspension parts via preforming the workpiece by roll forming. The sectional area and length of the workpiece are calculated. In the former step, more than one orthogonal cross-section is acquired from the suspension part of aluminum alloy, and the sectional area is converted into the area of a circle. An imaginary area is calculated by adding to the converted area an adequate amount of flash. In the latter step, a circular truncated cone is defined from two adjacent imaginary circles and the length of the imaginary center line between the two adjacent imaginary circles. A solid of revolution is defined by connecting these circular truncated cones, and the volume of the suspension part of aluminum alloy is substituted by the volume of the solid of revolution. The value obtained by dividing the sectional area of the workpiece by the volume is regarded as the-length of the workpiece.

Abstract: A method for determining the dimensions of the workpiece that can be roll-formed for preforming. A method for producing suspension parts via preforming the workpiece by roll forming.